Alexander Ginsburg, who heads the Gamaleya Institute that developed Sputnik V, said the spray for children used the same vaccine "only instead of a needle, a nozzle is put on", the TASS news agency reported.
The children's shot is expected to be ready for distribution by Sept. 15, Gintsburg was quoted as saying during a meeting with President Vladimir Putin.
Authorities in the financial hub are struggling to boost the inoculation rate among the city's 7.5 million population, and Hong Kong's government, on Monday, said it would offer vaccinated civil servants two days off as an incentive for getting a shot.
Israel's inflation rate moved to 0.8% in April from 0.2% in March, just below the government's 1-3% annual target range. While the economy contracted an annualised 6.5% in the first quarter from the prior three months, growth is expected to reach 4-6% in 2021 given more than half of Israeli adults are already vaccinated and the economy has largely reopened.
"It's an extremely rare event. We hope by making people aware as well as putting clear diagnostic and therapeutic guidance in place that we can restore the confidence in our vaccine," said J&J's Chief Scientific Officer Paul Stoffels.
J&J, during a call to discuss its first-quarter results, said it would fulfill its commitments to ship 200 million doses in Europe and 100 million in the United States.
"The original strain of COVID-19 comprises only about half of all cases in America today. New and potentially dangerous strains of the virus make up the other half," the White House said in a statement.
The White House also offered a state-by-state breakdown of the funds with California receiving over $17 million, Texas over $15 million and Florida over $12 million.
While we (Discovery) might be in contact with vaccine manufacturers, the acquisition of the vaccine and the policy for who receives it and in what sequence remains the exclusive responsibility of government, until such time as government informs otherwise.
South Africa's vaccine rollout faced a blow in early February when it decided to halt the rollout of AstraZeneca's shots on concerns about its effectiveness against the 501Y.V2 variant.
Turkey has until now been using COVID-19 vaccines developed by Sinovac, received as part of an agreement to procure a total of 100 million doses, and has administered 14.6 million shots, with 8.2 million people having received a first dose, since Jan. 14 when the nationwide rollout began. On Thursday, Turkey said it has begun initial talks to procure Russia's Sputnik-V shot.
"We do not know if the cases are linked to the vaccine," Sigurd Hortemo, a senior doctor at the Norwegian Medicines Agency told a news conference held jointly with the Norwegian Institute of Public Health.
The European medicine regulator EMA would investigate the three incidents, Hortemo added.